Trillium Therapeutics Inc. (TRIL) had a final net worth of $1.9 billion on September 30, 2021, which was the date the company was delisted from the stock market.
Trillium Therapeutics Inc. Valuation Overview
Trillium Therapeutics Inc. was a biotechnology company whose net worth, often referred to as market capitalization for publicly traded entities, fluctuated over its operational period. Its valuation was historically tracked until its cessation as a publicly traded company. The last reported net worth provides a snapshot of its market value at the time of its delisting.
Key Metrics at Delisting
The table below summarizes the final reported valuation details for Trillium Therapeutics Inc.:
| Key Metric | Value |
|---|---|
| Final Net Worth | $1.9 Billion |
| Delisting Date | Sep 30, 2021 |
Understanding Corporate Net Worth for Delisted Companies
For a company that has been delisted, its "net worth" no longer represents a live, publicly traded market capitalization. Instead, it refers to the last recorded market value before it ceased to be traded on a major exchange. This typically occurs due to an acquisition, merger, or other corporate actions that result in the company no longer being an independent, publicly listed entity. In the case of Trillium Therapeutics Inc., the $1.9 billion figure represents its market valuation on the final day it was tracked on the public markets.
